New FDA Guidances Aim to Reduce Number of Review Cycles By Sam | September 24, 2018 The FDA released two new guidances Monday to help speed reviews of generic drugs and get the products to market more quickly. Source: Drug Industry Daily Posted in Drug Industry Daily